Under the global financial crisis in 2009, Guangdong finally withstood the economic turmoil has created an increase of 9.5% of GDP performance, many economic data in the face a decline in the situation, Guangdong has achieved easily leap biomedical contrarian gains across the board: total industrial output value of biological products in Guangdong rose about 48%, exports grew by about 7 times; medicine manufacturing industrial added value increased by 18.3% significantly contrarian, ranking No. 3.

However, bigger is clearly not enough, and strong is the Guangdong Provincial Government in the biomedical industry, the final goal. From years ago, “Private non-profit” in biomedical innovation platform, “South China Drug Discovery Center” established in March of this year, the Guangdong provincial government-led advance the biomedical industry in Guangdong Province to promote joint innovation and Guangdong in the biomedical the pace of independent innovation, more and more. The Guangdong biomedical innovation through reform mechanisms and functions of government functions chain, integrating the power of multi- and the government will also promote the development of Guangdong Province, the two bio-pharmaceutical industry change: Factor-driven to innovation-driven shift from large biomedical Provincial changes to the biomedical province.

Guangdong ranks first in the development of bio-medicine

According to “The People’s Republic of China national economic and social development of the Eleventh Five-Year Plan” and the “bio-industry development,” Eleventh Five-Year “plan” requirement, by 2010, bio-pharmaceutical industrial added value will reach 500 billion yuan above. The 2020 National Biological industrial added value will exceed 2 trillion yuan, to become the pillar industry of high-tech areas and the national economy’s leading industries. Biomedicine as competition on regional economic development strategy must fight Heights.

Guangdong Traditional Chinese Medicine is very rich, up to more than 2600 kinds of medicinal species, accounting for 20.7%, which is one of the main producing areas of Chinese herbal medicines nationwide, specialty “Southern medicine” varieties of unique advantages, as a province of China the status of Chinese medicine not only from the output of Chinese medicine products, but also from the quality of Chinese products. Years ago, the financial crisis sweeping the globe, “South medicine” in particular, modern bio-medicine industry of Guangdong showed strong shock resistance, bio-pharmaceutical industry has become an important engine of economic growth. The development of a set of industry data shows this trend: in 2008 industrial output value of Chinese Medicine of Guangdong Province at about 75 billion yuan, up 25%, ranking No. 3; health products output reached 30 billion yuan, accounting for Jin Sicheng share. In 2009, Guangdong pharmaceutical industry output value expected to be 92 billion yuan, an increase of about 22.6%, of which the medical device industry output value of about 310 billion yuan, up about 25%, ranking No. 1.

Present, Guangdong has initially established a relatively complete, technologically advanced, better product quality, bio-pharmaceutical industry system, in the biopharmaceutical, gene diagnostic reagents, modern medicine, medical equipment is strong in the areas of . Guangdong biomedical industry employing nearly 10 people present, there Zhongshan University, Southern Medical University, Jinan University, Chinese Academy of Sciences Guangzhou Institute of Biomedicine and health related institutions of higher learning and research institutes. The province formed a broad drug development, 39 other pharmaceutical companies, now owns Guangzhou Pharmaceutical, Baiyun Mountain, 39 medicine, Mrs. medicine, Lizhu Group, Kang Pharmaceutical and a number of U.S. pharmaceutical companies, which ranked first in the country. With the huge market potential and good investment environment, Guangdong has attracted Novartis, Bayer, Roche and other multinational pharmaceutical companies to invest in the development.

The idea that Japan used for one day. Guangdong’s rapid development of biological pharmaceutical industry, in the sudden international health crisis, played a significant role, both in the effective response to SARS, avian flu or infectious diseases such as influenza H1N1 in Guangdong have become the international biomedical eye-catching star.

“Last year, including bio-medicine, including high-tech industry amounted to more than 20,000 billion yuan, accounting for 31% of the total value of industry.” Guangdong Governor Huang Huahua that the development of Guangdong, biomedical science and technology is very good industry environment. Huang Huahua said biomedical output in Guangdong and development ranks first in the country reached 100,000 employees, with Zhongshan University, Jinan University, Southern Medical University, so a large number of scientific research base.
-
About the Author:
I am a professional writer from China Manufacturers, which contains a great deal of information about washing machine spare parts , infrared heaters electric, welcome to visit!
Article Source